Detection of tumor specific changes in nucleic acids in body fluids of patientswith malignancies
Recruiting
- Conditions
- all types of tumor
- Registration Number
- DRKS00009521
- Lead Sponsor
- niversitätsklinikum Freiburg
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 1000
Inclusion Criteria
none
Exclusion Criteria
none
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Proportion of patients with malignant disease and a known tumor-specific , genetic<br>Change detection with the corresponding genetic modification in a<br>Body fluid such as blood, plasma, saliva or urine
- Secondary Outcome Measures
Name Time Method - Correlation of detection of tumor-specific , genetic alterations in<br>Body fluids with the clinical course ( imaging : recurrence , response ) and<br>clinical endpoints<br>- Correlation of detection of tumor-specific , genetic alterations in<br>Body fluids with clinical endpoints (progressionfree- and overall survival )